Researchers identify mutations that can lead to resistance to some chemotherapies
Saturday, 29 March 2025 ()
Investigators have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study found that mutations to VPS35, a key player in this pathway, can prevent chemotherapy-induced cell death. These results could help pinpoint treatment-resistant tumors.
|
||||
|
|
||||
You Might Like |
||||
